Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析

◆英語タイトル:Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13800
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sino Biopharmaceutical Ltd (1177) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sino Biopharmaceutical Ltd (Sino Biopharma), a subsidiary of CP Pharmaceutical Group, is a research driven pharmaceutical company that develops, manufactures, and markets chemicals, biopharmaceuticals and Chinese medicines. It offers medicines for the treatment of hepatitis, cardio-cerebral diseases, cancer, orthopedic diseases, infectious diseases, diabetes, respiratory, and anorectal diseases. The company offers its products in various dosage forms including large volume injections, PVC-free soft bags for intravenous (IV) injections, small volume injections, powdered medicines, granulated medicines, capsules, and tablets. It works in partnership with several domestic and foreign pharmaceutical companies to advance the development of its products. Sino Biopharma along with its subsidiaries is headquartered in Hong Kong.

Sino Biopharmaceutical Ltd Key Recent Developments

Dec 06,2018: Chinese pharmaceutical stocks plunge on bigger than expected price cuts of generic drugs on compulsory bulk tendering
Apr 26,2018: Sino Biopharmaceutical: Successful Inclusion of Six Products of the Group Into Jiangsu Medical Insurance Catalogue
Mar 22,2018: Sino Biopharmaceutical: Annual Results Announcement For The Year Ended 31 December, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sino Biopharmaceutical Ltd – Key Facts
Sino Biopharmaceutical Ltd – Key Employees
Sino Biopharmaceutical Ltd – Key Employee Biographies
Sino Biopharmaceutical Ltd – Major Products and Services
Sino Biopharmaceutical Ltd – History
Sino Biopharmaceutical Ltd – Company Statement
Sino Biopharmaceutical Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sino Biopharmaceutical Ltd – Business Description
Product Category: Anti-infectious Medicines
Overview
Product Category: Analgesic Medicines
Overview
Performance
Product Category: Anorectal Medicines
Overview
Performance
Product Category: Anti-Infectious Medicines
Performance
Product Category: Cardio-Cerebral Medicines
Overview
Performance
Product Category: Diabetic Medicines
Overview
Performance
Product Category: Hepatitis Medicines
Overview
Performance
Product Category: Oncology Medicines
Overview
Performance
Product Category: Orthopedic Medicines
Overview
Performance
Product Category: Parenteral Nutritious Medicines
Overview
Performance
Product Category: Respiratory System Medicines
Overview
Performance
R&D Overview
Sino Biopharmaceutical Ltd – Corporate Strategy
Sino Biopharmaceutical Ltd – SWOT Analysis
SWOT Analysis – Overview
Sino Biopharmaceutical Ltd – Strengths
Sino Biopharmaceutical Ltd – Weaknesses
Sino Biopharmaceutical Ltd – Opportunities
Sino Biopharmaceutical Ltd – Threats
Sino Biopharmaceutical Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Sino Biopharmaceutical Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 26, 2018: Sino Biopharmaceutical: Successful Inclusion of Six Products of the Group Into Jiangsu Medical Insurance Catalogue
Mar 22, 2018: Sino Biopharmaceutical: Annual Results Announcement For The Year Ended 31 December, 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sino Biopharmaceutical Ltd, Key Facts
Sino Biopharmaceutical Ltd, Key Employees
Sino Biopharmaceutical Ltd, Key Employee Biographies
Sino Biopharmaceutical Ltd, Major Products and Services
Sino Biopharmaceutical Ltd, History
Sino Biopharmaceutical Ltd, Other Locations
Sino Biopharmaceutical Ltd, Subsidiaries
Sino Biopharmaceutical Ltd, Key Competitors
Sino Biopharmaceutical Ltd, Ratios based on current share price
Sino Biopharmaceutical Ltd, Annual Ratios
Sino Biopharmaceutical Ltd, Annual Ratios (Cont...1)
Sino Biopharmaceutical Ltd, Annual Ratios (Cont...2)
Sino Biopharmaceutical Ltd, Interim Ratios
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Sino Biopharmaceutical Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sino Biopharmaceutical Ltd, Performance Chart (2013 - 2017)
Sino Biopharmaceutical Ltd, Ratio Charts
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Orbit Garant Drilling Inc.:企業の戦略・SWOT・財務情報
    Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report Summary Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kentucky Power Co:企業の戦略的SWOT分析
    Kentucky Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Nikkei Inc.:企業の戦略的SWOT分析
    Nikkei Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vectura Group Plc (VEC):医療機器:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • ImevaX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops novel vaccines to prevent chronic and nosocomial infections. Its lead product candidate IMX101, an immune evasion vaccine, is indicated for the treatment of Helicobacter pylori. Its pipeline products include IMA101 mucosal adj …
  • Epigenomics AG (ECX):企業の製品パイプライン分析
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Greenphire Inc-医療機器分野:企業M&A・提携分析
    Summary Greenphire Inc (Greenphire) is a provider of clinical trial payment solutions which offers site payments and paitent reimbursement. Its product portfolio includes eClinicalGPS and ClinCard. The eClinicalGPS is a global site that facilitates accurate payment calculation, manages complex payme …
  • Chubu Electric Power Co Inc (9502):電力:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • Ascendis Pharma AS (ASND):製薬・医療:M&Aディール及び事業提携情報
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PT Pembangkitan Jawa-Bali-エネルギー分野:企業M&A・提携分析
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務分析
    Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dexia Group:企業のM&A・事業提携・投資動向
    Dexia Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexia Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Miele & Cie. KG:企業の戦略的SWOT分析
    Miele & Cie. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Maersk Drilling AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Drilling A/S (Maersk) formerly Maersk Contractors, a subsidiary of A.P. Moller - Maersk A/S, is an oil and gas company that offers drilling services. The company operates a fleet of drilling barges such as smaller rigs optimized for shallow water drilling and operated on management co …
  • Odakyu Electric Railway:企業の戦略・SWOT・財務分析
    Odakyu Electric Railway - Strategy, SWOT and Corporate Finance Report Summary Odakyu Electric Railway - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • F-star Biotechnology Ltd-製薬・医療分野:企業M&A・提携分析
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆